Neuren Pharmaceuticals Ltd
F:NK9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuren Pharmaceuticals Ltd
F:NK9
|
AU |
|
Bombardier Inc
F:BBD
|
CA |
|
Pharming Group NV
NASDAQ:PHAR
|
NL |
|
Q2 Metals Corp
XTSX:QTWO
|
CA |
|
Lynas Rare Earths Ltd
XMUN:LYI
|
AU |
|
Posco Holdings Inc
KRX:005490
|
KR |
|
Western Forest Products Inc
OTC:WFSTD
|
CA |
|
Mediaalpha Inc
NYSE:MAX
|
US |
|
Organovo Holdings Inc
NASDAQ:VIVS
|
US |
|
H
|
Heng Leasing and Capital PCL
SET:HENG
|
TH |
|
B
|
Balchem Corp
SWB:BL9B
|
US |
|
C
|
Clearside Biomedical Inc
DUS:CLM
|
US |
|
La Francaise de l Energie SA
PAR:FDE
|
FR |
|
Euro Sun Mining Inc
TSX:ESM
|
CA |
|
L
|
Leonardo SpA
XMUN:FMNB
|
IT |
|
G
|
Gladstone Commercial Corp
F:GLE
|
US |
|
I
|
Infratil Ltd
ASX:IFT
|
NZ |
|
T
|
Teledyne Technologies Inc
F:TYZ
|
US |
|
P
|
PDF Solutions Inc
F:PD9
|
US |
|
C
|
Clearside Biomedical Inc
F:CLM
|
US |
|
Informa PLC
LSE:INF
|
UK |
|
Premia Finance SpA Societa di Mediazione Creditizia
MIL:PFI
|
IT |
|
Infinity Lithium Corporation Ltd
ASX:INF
|
AU |
|
V
|
voestalpine AG
XHAM:VAS
|
AT |
Shareholder Yield
Current shareholder yield for 
NK9 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NK9 Price
Neuren Pharmaceuticals Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -42% |
| Market Capitalization | 2.2B EUR |
| Shares Outstanding | 126 640 000 |
| Percentage of Shares Shorted |
N/A
|
